Gelatin Methacryloyl Hydrogels for Musculoskeletal Tissue Regeneration

Yang Hee Kim; Jonathan I. Dawson; Richard O.C. Oreffo; Yasuhiko Tabata; Dhiraj Kumar; Conrado Aparicio; Isha Mutreja

doi:10.3390/bioengineering9070332

Gelatin Methacryloyl Hydrogels for Musculoskeletal Tissue Regeneration

Yang Hee Kim, Jonathan I. Dawson, Richard O.C. Oreffo, Yasuhiko Tabata, Dhiraj Kumar, Conrado Aparicio, Isha Mutreja

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

Musculoskeletal disorders are a significant burden on the global economy and public health. Hydrogels have significant potential for enhancing the repair of damaged and injured musculoskeletal tissues as cell or drug delivery systems. Hydrogels have unique physicochemical properties which make them promising platforms for controlling cell functions. Gelatin methacryloyl (GelMA) hydrogel in particular has been extensively investigated as a promising biomaterial due to its tuneable and beneficial properties and has been widely used in different biomedical applications. In this review, a detailed overview of GelMA synthesis, hydrogel design and applications in regenerative medicine is provided. After summarising recent progress in hydrogels more broadly, we highlight recent advances of GelMA hydrogels in the emerging fields of musculoskeletal drug delivery, involving therapeutic drugs (e.g., growth factors, antimicrobial molecules, immunomodulatory drugs and cells), delivery approaches (e.g., single-, dual-release system), and material design (e.g., addition of organic or inorganic materials, 3D printing). The review concludes with future perspectives and associated challenges for developing local drug delivery for musculoskeletal applications.

Original language	English (US)
Article number	332
Journal	Bioengineering
Volume	9
Issue number	7
DOIs	https://doi.org/10.3390/bioengineering9070332
State	Published - Jul 21 2022

Bibliographical note

Funding Information:
Y.-H.K., R.O.C.O. and J.I.D. gratefully acknowledge support from the MRC-AMED Regenerative Medicine and Stem Cell Research Initiative (MR/V00543X/1) and the EPSRC (EP/S017054/1). R.O.C.O. acknowledges financial support from the Biotechnology and Biological Sciences Research Council (BB/P017711/1) and the UK Regenerative Medicine Platform “Acellular/Smart Materials—3D Architecture” (MR/R015651/1). I.M. and C.A. acknowledge the financial support from the Assistant Secretary of Defence for Health Affairs through the Peer Reviewed Orthopaedic Research Program (PRORP) under Applied Research Award No. W81XWH-20-1-0563. Army Medical Research Acquisition Activity, 839 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defence. I.M. also acknowledges the financial support from the University of Minnesota’s Office of Academic Clinical Affairs Faculty Research Development Grant.

Funding Information:
This research was funded by MRC-AMED Regenerative Meicine and Stem ell Research Initiative (MR/V00543X/1), EPSRC (EP/S017054/1), Biotechnology and Biological Sciences Research Council (BB/P017711/1), UK Regenerative Medicine Platform “Acellular/Smart Materials—3D Architecture” (MR/R015651/1), Assistant Secretary of Defence for Health Affairs through the Peer Reviewed Orthopaedic Research Program (PRORP) under Applied Research Award (No W81XWH-20-1-0563), Army Medical Research Acquisition Activity, 839 Chandler Street, Fort Detrick MD 21702-5014, and the University of Minnesota’s Office of Academic Clinical Affairs Faculty Research Development Grant.

Publisher Copyright:
© 2022 by the authors.

Keywords

drug delivery
gelatin
GelMA
hydrogel
musculoskeletal tissue

PubMed: MeSH publication types

Journal Article
Review

Publisher link

10.3390/bioengineering9070332

https://www.mdpi.com/2306-5354/9/7/332/pdf?version=1658406433License: CC BY

Find It

Find It at U of M Libraries

Cite this

@article{78805536b9dc4d20a94b5cbff12e4d4c,

title = "Gelatin Methacryloyl Hydrogels for Musculoskeletal Tissue Regeneration",

abstract = "Musculoskeletal disorders are a significant burden on the global economy and public health. Hydrogels have significant potential for enhancing the repair of damaged and injured musculoskeletal tissues as cell or drug delivery systems. Hydrogels have unique physicochemical properties which make them promising platforms for controlling cell functions. Gelatin methacryloyl (GelMA) hydrogel in particular has been extensively investigated as a promising biomaterial due to its tuneable and beneficial properties and has been widely used in different biomedical applications. In this review, a detailed overview of GelMA synthesis, hydrogel design and applications in regenerative medicine is provided. After summarising recent progress in hydrogels more broadly, we highlight recent advances of GelMA hydrogels in the emerging fields of musculoskeletal drug delivery, involving therapeutic drugs (e.g., growth factors, antimicrobial molecules, immunomodulatory drugs and cells), delivery approaches (e.g., single-, dual-release system), and material design (e.g., addition of organic or inorganic materials, 3D printing). The review concludes with future perspectives and associated challenges for developing local drug delivery for musculoskeletal applications.",

keywords = "drug delivery, gelatin, GelMA, hydrogel, musculoskeletal tissue",

author = "Kim, {Yang Hee} and Dawson, {Jonathan I.} and Oreffo, {Richard O.C.} and Yasuhiko Tabata and Dhiraj Kumar and Conrado Aparicio and Isha Mutreja",

note = "Funding Information: Y.-H.K., R.O.C.O. and J.I.D. gratefully acknowledge support from the MRC-AMED Regenerative Medicine and Stem Cell Research Initiative (MR/V00543X/1) and the EPSRC (EP/S017054/1). R.O.C.O. acknowledges financial support from the Biotechnology and Biological Sciences Research Council (BB/P017711/1) and the UK Regenerative Medicine Platform “Acellular/Smart Materials—3D Architecture” (MR/R015651/1). I.M. and C.A. acknowledge the financial support from the Assistant Secretary of Defence for Health Affairs through the Peer Reviewed Orthopaedic Research Program (PRORP) under Applied Research Award No. W81XWH-20-1-0563. Army Medical Research Acquisition Activity, 839 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defence. I.M. also acknowledges the financial support from the University of Minnesota{\textquoteright}s Office of Academic Clinical Affairs Faculty Research Development Grant. Funding Information: This research was funded by MRC-AMED Regenerative Meicine and Stem ell Research Initiative (MR/V00543X/1), EPSRC (EP/S017054/1), Biotechnology and Biological Sciences Research Council (BB/P017711/1), UK Regenerative Medicine Platform “Acellular/Smart Materials—3D Architecture” (MR/R015651/1), Assistant Secretary of Defence for Health Affairs through the Peer Reviewed Orthopaedic Research Program (PRORP) under Applied Research Award (No W81XWH-20-1-0563), Army Medical Research Acquisition Activity, 839 Chandler Street, Fort Detrick MD 21702-5014, and the University of Minnesota{\textquoteright}s Office of Academic Clinical Affairs Faculty Research Development Grant. Publisher Copyright: {\textcopyright} 2022 by the authors.",

year = "2022",

month = jul,

day = "21",

doi = "10.3390/bioengineering9070332",

language = "English (US)",

volume = "9",

journal = "Bioengineering",

publisher = "MDPI AG",

number = "7",

}

TY - JOUR

T1 - Gelatin Methacryloyl Hydrogels for Musculoskeletal Tissue Regeneration

AU - Kim, Yang Hee

AU - Dawson, Jonathan I.

AU - Oreffo, Richard O.C.

AU - Tabata, Yasuhiko

AU - Kumar, Dhiraj

AU - Aparicio, Conrado

AU - Mutreja, Isha

N1 - Funding Information: Y.-H.K., R.O.C.O. and J.I.D. gratefully acknowledge support from the MRC-AMED Regenerative Medicine and Stem Cell Research Initiative (MR/V00543X/1) and the EPSRC (EP/S017054/1). R.O.C.O. acknowledges financial support from the Biotechnology and Biological Sciences Research Council (BB/P017711/1) and the UK Regenerative Medicine Platform “Acellular/Smart Materials—3D Architecture” (MR/R015651/1). I.M. and C.A. acknowledge the financial support from the Assistant Secretary of Defence for Health Affairs through the Peer Reviewed Orthopaedic Research Program (PRORP) under Applied Research Award No. W81XWH-20-1-0563. Army Medical Research Acquisition Activity, 839 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defence. I.M. also acknowledges the financial support from the University of Minnesota’s Office of Academic Clinical Affairs Faculty Research Development Grant. Funding Information: This research was funded by MRC-AMED Regenerative Meicine and Stem ell Research Initiative (MR/V00543X/1), EPSRC (EP/S017054/1), Biotechnology and Biological Sciences Research Council (BB/P017711/1), UK Regenerative Medicine Platform “Acellular/Smart Materials—3D Architecture” (MR/R015651/1), Assistant Secretary of Defence for Health Affairs through the Peer Reviewed Orthopaedic Research Program (PRORP) under Applied Research Award (No W81XWH-20-1-0563), Army Medical Research Acquisition Activity, 839 Chandler Street, Fort Detrick MD 21702-5014, and the University of Minnesota’s Office of Academic Clinical Affairs Faculty Research Development Grant. Publisher Copyright: © 2022 by the authors.

PY - 2022/7/21

Y1 - 2022/7/21

N2 - Musculoskeletal disorders are a significant burden on the global economy and public health. Hydrogels have significant potential for enhancing the repair of damaged and injured musculoskeletal tissues as cell or drug delivery systems. Hydrogels have unique physicochemical properties which make them promising platforms for controlling cell functions. Gelatin methacryloyl (GelMA) hydrogel in particular has been extensively investigated as a promising biomaterial due to its tuneable and beneficial properties and has been widely used in different biomedical applications. In this review, a detailed overview of GelMA synthesis, hydrogel design and applications in regenerative medicine is provided. After summarising recent progress in hydrogels more broadly, we highlight recent advances of GelMA hydrogels in the emerging fields of musculoskeletal drug delivery, involving therapeutic drugs (e.g., growth factors, antimicrobial molecules, immunomodulatory drugs and cells), delivery approaches (e.g., single-, dual-release system), and material design (e.g., addition of organic or inorganic materials, 3D printing). The review concludes with future perspectives and associated challenges for developing local drug delivery for musculoskeletal applications.

AB - Musculoskeletal disorders are a significant burden on the global economy and public health. Hydrogels have significant potential for enhancing the repair of damaged and injured musculoskeletal tissues as cell or drug delivery systems. Hydrogels have unique physicochemical properties which make them promising platforms for controlling cell functions. Gelatin methacryloyl (GelMA) hydrogel in particular has been extensively investigated as a promising biomaterial due to its tuneable and beneficial properties and has been widely used in different biomedical applications. In this review, a detailed overview of GelMA synthesis, hydrogel design and applications in regenerative medicine is provided. After summarising recent progress in hydrogels more broadly, we highlight recent advances of GelMA hydrogels in the emerging fields of musculoskeletal drug delivery, involving therapeutic drugs (e.g., growth factors, antimicrobial molecules, immunomodulatory drugs and cells), delivery approaches (e.g., single-, dual-release system), and material design (e.g., addition of organic or inorganic materials, 3D printing). The review concludes with future perspectives and associated challenges for developing local drug delivery for musculoskeletal applications.

KW - drug delivery

KW - gelatin

KW - GelMA

KW - hydrogel

KW - musculoskeletal tissue

UR - http://www.scopus.com/inward/record.url?scp=85136189349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85136189349&partnerID=8YFLogxK

U2 - 10.3390/bioengineering9070332

DO - 10.3390/bioengineering9070332

M3 - Review article

C2 - 35877383

VL - 9

JO - Bioengineering

JF - Bioengineering

IS - 7

M1 - 332

ER -

Gelatin Methacryloyl Hydrogels for Musculoskeletal Tissue Regeneration

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

Publisher link

Find It

Other files and links

Fingerprint

Cite this